Baylor Genetics has added optical genome mapping and long-read sequencing to its whole genome sequencing test, expanding STR analysis, enabling FMR1 methylation detection, and improving structural variant interpretation.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
Droplet Biosciences reports reducing genomic analysis time from days to hours for its LymphDetect test by adopting NVIDIA Parabricks GPU-accelerated software.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
Insight Molecular Diagnostics has completed clinical validation and received ISO 13485 certification for its GraftAssureDx kidney transplant rejection test kit, moving toward FDA submission, according to the company.
